This statistic depicts the number of manufacturing plants producing quasi-drugs in Japan in 2016, broken down by region. During the measured period, the Kanto-Etsusei region had, with 261 plants, the largest number of quasi-drugs manufacturing plants in Japan, followed by Kinki with around 203 plants producing quasi-drugs.
Number of manufacturing plants producing quasi-drugs in Japan in 2016, by region
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$189 USD $149 USD / Month *
in the first 12 months
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Medicated cosmetics production quantity in Japan 2016, by item
- Premium Statistic Hair remedies production quantity in Japan 2016, by item
- Premium Statistic Quasi drugs production value in Japan 2012-2021
- Premium Statistic Quasi drugs production value in Japan 2021, by therapeutic category
- Premium Statistic Breakdown of quasi-drugs production in Japan 2021, by therapeutic category
- Premium Statistic Biopharmaceuticals market value in Latin America 2022-2027
- Premium Statistic Antibodies market value in Latin America 2022-2027
- Basic Statistic Annual revenue of Sobi 2009-2022
- Basic Statistic Gross profit of Sobi 2009-2022
- Basic Statistic Annual profit/loss of Sobi 2009-2022
About the region
10
- Premium Statistic Sawai Pharmaceutical's total assets FY 2011-2020
- Premium Statistic Sawai's drug sales share in Japan FY 2018, by institution
- Premium Statistic Number of medical drug manufacturing plants Japan 2018, by employee size
- Premium Statistic Major drug manufacturers Japan 2017, by number of products
- Premium Statistic Number of quasi-drugs approved by PMDA Japan FY 2012-2021
- Premium Statistic Number of prescription drugs approved by PMDA Japan FY 2015-2021, by type
- Premium Statistic Number of BTC and OTC drugs approved by PMDA Japan FY 2012-2021
- Premium Statistic Hair remedies production amount in Japan 2021, by item
- Premium Statistic Drug production value of cardiovascular agents Japan 2021, by category
- Premium Statistic Sales value of leading drugs Japan FY 2021
Selected statistics
8
- Premium Statistic Global pharmaceutical pipeline by therapy area 2013-2017
- Basic Statistic Sanofi's total assets 2007-2022
- Premium Statistic Pfizer's revenues in the U.S. and abroad 2009-2022
- Premium Statistic AstraZeneca's expenditure on research and development 2006-2022
- Premium Statistic Johnson & Johnson's number of employees 2004-2022
- Premium Statistic Sales of Johnson & Johnson worldwide 2011-2022, by segment
- Premium Statistic Sales of Johnson & Johnson 2006-2022 by region
- Premium Statistic U.S. branded prescription revenue forecast 2009-2015
Other regions
10
- Basic Statistic Revenue of self-care medicines in the Netherlands 2022, by product segment
- Premium Statistic Massachusetts' medical cannabis spending 2018-2024
- Basic Statistic Pharmacy revenue share in Sweden 2022, by type of product
- Basic Statistic Top U.S. oncology products by revenue in 2016
- Basic Statistic Usage rate of top drug classes prescribed to seniors in Canada 2016, by age
- Basic Statistic Oregon's medical cannabis sales value U.S. 2018-2024
- Basic Statistic Nevada's medical cannabis spending 2018-2024
- Basic Statistic Vermont's medical cannabis sales value U.S. 2018-2024
- Basic Statistic Maine's medical cannabis spending 2018-2024
- Basic Statistic Alaska's medical cannabis spending 2018-2024
Related statistics
10
- Premium Statistic Number of NME approved Japan 2013-2022
- Premium Statistic Pharmaceutical drug production value Japan 2018, by plant size
- Premium Statistic Drug production value share of digestive organ agents Japan 2018, by category
- Premium Statistic Pharmaceutical market size Japan 2008-2015
- Premium Statistic Biopharmaceutical market size forecast Japan 2011-2020
- Premium Statistic Towa Pharmaceutical's profit FY 2012-2017
- Premium Statistic Designated quasi drugs market shipment value in Japan 2010-2019
- Premium Statistic OTC drugs market shipment value in Japan 2010-2019
- Premium Statistic Astellas Pharma's net profit FY 2013-2022
- Premium Statistic Number of in vitro diagnostics approved by PMDA Japan FY 2012-2021
Further related statistics
10
- Pfizer's ad spending 2008-2022
- CVS Health's total assets 2005-2022
- Cost savings through urgent care vs emergency department 2012
- AstraZeneca's revenue from top product Pulmicort 2006-2022
- Total assets of UnitedHealth Group 2007-2022
- Walgreens gross profit and net earnings in the U.S. 2005-2022
- Medicaid long-term care services expenditures by type of service 1990-21
- Global oil production share 2010-2022, by region
- Global oil production share 2022, by country
- Number of employees at Sinopharm 2011-2022
Further Content: You might find this interesting as well
Statistics
- Pfizer's ad spending 2008-2022
- CVS Health's total assets 2005-2022
- Cost savings through urgent care vs emergency department 2012
- AstraZeneca's revenue from top product Pulmicort 2006-2022
- Total assets of UnitedHealth Group 2007-2022
- Walgreens gross profit and net earnings in the U.S. 2005-2022
- Medicaid long-term care services expenditures by type of service 1990-21
- Global oil production share 2010-2022, by region
- Global oil production share 2022, by country
- Number of employees at Sinopharm 2011-2022
MHLW (Japan). (September 20, 2018). Number of manufacturing plants producing quasi-drugs in Japan in 2016, by region [Graph]. In Statista. Retrieved September 25, 2023, from https://www.statista.com/statistics/821081/japan-quasi-drugs-manufacturing-plants-by-region/
MHLW (Japan). "Number of manufacturing plants producing quasi-drugs in Japan in 2016, by region." Chart. September 20, 2018. Statista. Accessed September 25, 2023. https://www.statista.com/statistics/821081/japan-quasi-drugs-manufacturing-plants-by-region/
MHLW (Japan). (2018). Number of manufacturing plants producing quasi-drugs in Japan in 2016, by region. Statista. Statista Inc.. Accessed: September 25, 2023. https://www.statista.com/statistics/821081/japan-quasi-drugs-manufacturing-plants-by-region/
MHLW (Japan). "Number of Manufacturing Plants Producing Quasi-drugs in Japan in 2016, by Region." Statista, Statista Inc., 20 Sep 2018, https://www.statista.com/statistics/821081/japan-quasi-drugs-manufacturing-plants-by-region/
MHLW (Japan), Number of manufacturing plants producing quasi-drugs in Japan in 2016, by region Statista, https://www.statista.com/statistics/821081/japan-quasi-drugs-manufacturing-plants-by-region/ (last visited September 25, 2023)
Number of manufacturing plants producing quasi-drugs in Japan in 2016, by region [Graph], MHLW (Japan), September 20, 2018. [Online]. Available: https://www.statista.com/statistics/821081/japan-quasi-drugs-manufacturing-plants-by-region/